4Zuberi SJ,Khan AQ,Irshad-ul-Haque I,et al.Roxatidine versus ranitidine in the treatment of patients with duodenal ulcer:a randomized,double-masked,multicenter study[J].Clin Ther,1996,18:1207-1212.
5Yasutake K,Amano M,Mizokami Y,et al.Effects of changing the type of H2-blocker in the treatment of H2-blocker-resistant ulcers:comparison of roxatidine acetate hydrochloride and other H2-blockers[J].J Int Med Res,1998,26(1):25-36.
6Murdoch D,McTavish D.Roxatidine acetate:A review of its pharmacodynamic and pharmacokinetic properties,and its therapeutic potential in peptic ulcer disease and related disorders[J].Drugs,1991,42:240-260.
7Muller P,Jackisch P,Simon B.Circadian aspects of diclofenac gastroduodenopathy and the protective effect of roxatidine[J].Z Rheumatol,1993,52:297-300.
9Sasaki M,Nakayama M,Numazawa S,et al.Cytochrome P450 enzymes involved in the metabolic pathway of the histamine 2 (H2)-receptor antagonist roxatidine acetate by human liver microsomes[J].Arzneimittelforschung,2001,51:651-658.
10Namba M,Chihara E,Ibuki T,et al.Clinical evaluation of roxatidine acetate hydrochlorides as a preanesthetic medication[J].Masui,2001,50:127-135.
